MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines

2 weeks ago 13

April 22, 2024- The University of Texas MD Anderson Cancer Center and CureVac N.V. announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates...